Staar Surgical (NASDAQ:STAA) underwent analysis by 7 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
4
0
3
0
0
Last 30D
1
0
0
0
0
1M Ago
0
0
0
0
0
2M Ago
1
0
2
0
0
3M Ago
2
0
1
0
0
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $47.57, along with a high estimate of $55.00 and a low estimate of $40.00. This upward trend is apparent, with the current average reflecting a 10.19% increase from the previous average price target of $43.17.
Understanding Analyst Ratings: A Comprehensive Breakdown
The perception of Staar Surgical by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
Analyst
Analyst Firm
Action Taken
Rating
Current Price Target
Prior Price Target
Ryan Zimmerman
BTIG
Announces
Buy
$46.00
-
Jon Young
Canaccord Genuity
Lowers
Hold
$43.00
$46.00
Matt O'Brien
Piper Sandler
Raises
Neutral
$40.00
$33.00
Anthony Petrone
Mizuho
Raises
Buy
$55.00
$53.00
Anthony Petrone
Mizuho
Raises
Buy
$53.00
$45.00
Jon Young
Canaccord Genuity
Raises
Hold
$46.00
$32.00
Thomas Stephan
Stifel
Maintains
Buy
$50.00
$50.00
Key Insights:
Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Staar Surgical. This information provides a snapshot ...Full story available on Benzinga.com
Benzinga
